
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review
Description
Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Guy's and St Thomas' NHS Foundation Trust (Guy's and St Thomas'), a subsidiary of NHS England, is a major healthcare provider in the UK. It provides a range of general and specialist hospital services and community health services. Its major services include intensive care, emergency care, cancer treatment, cardiovascular and respiratory care, and transplant programs. The trust offers integrated acute and community healthcare services. Guy's and St Thomas' also include Evelina London Children’s Hospital. It serves local communities in Lambeth and Southwark and offers specialist care to patients from broader regions. It collaborates with academic and healthcare partners such as King’s Health Partners and Imperial Healthcare Partners. The Trust operates across multiple locations in south London, including Guy’s, St Thomas’, Royal Brompton, and Harefield hospitals. Guy’s and St Thomas’ is headquartered in London, the UK.
Guy's and St Thomas' NHS Foundation Trust Key Recent Developments
Jul 15,2024: Dr Claire Shannon elected Royal College of Anaesthetists President
Mar 28,2024: Guy's and St Thomas' NHS Foundation Trust Appoints New Chief People Officer
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Guy's and St Thomas' NHS Foundation Trust (Guy's and St Thomas'), a subsidiary of NHS England, is a major healthcare provider in the UK. It provides a range of general and specialist hospital services and community health services. Its major services include intensive care, emergency care, cancer treatment, cardiovascular and respiratory care, and transplant programs. The trust offers integrated acute and community healthcare services. Guy's and St Thomas' also include Evelina London Children’s Hospital. It serves local communities in Lambeth and Southwark and offers specialist care to patients from broader regions. It collaborates with academic and healthcare partners such as King’s Health Partners and Imperial Healthcare Partners. The Trust operates across multiple locations in south London, including Guy’s, St Thomas’, Royal Brompton, and Harefield hospitals. Guy’s and St Thomas’ is headquartered in London, the UK.
Guy's and St Thomas' NHS Foundation Trust Key Recent Developments
Jul 15,2024: Dr Claire Shannon elected Royal College of Anaesthetists President
Mar 28,2024: Guy's and St Thomas' NHS Foundation Trust Appoints New Chief People Officer
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
51 Pages
- Section 1 - About the Company
- Navamedic ASA - Key Facts
- Navamedic ASA - Key Employees
- Navamedic ASA - Key Employee Biographies
- Navamedic ASA - Major Products and Services
- Navamedic ASA - History
- Navamedic ASA - Company Statement
- Navamedic ASA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Navamedic ASA - Business Description
- Product Category: Consumer Health
- Performance
- Product Category: Hospital
- Performance
- Product Category: Precription Drugs (Rx)
- Performance
- Geographical Segment: Denmark
- Performance
- Geographical Segment: Finland
- Performance
- Geographical Segment: Norway
- Performance
- Geographical Segment: Other countries
- Performance
- Geographical Segment: Sweden
- Performance
- Geographical Segment: The Netherlands
- Performance
- Navamedic ASA - Corporate Strategy
- Navamedic ASA - SWOT Analysis
- SWOT Analysis - Overview
- Navamedic ASA - Strengths
- Navamedic ASA - Weaknesses
- Navamedic ASA - Opportunities
- Navamedic ASA - Threats
- Navamedic ASA - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Navamedic ASA, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Feb 12, 2025: Navamedic Q4 and Full Year 2024: Continued Growth in a Year with Investments in New Growth Initiatives
- Oct 31, 2024: Navamedic Q3 2024: Business Remains Strong in Quarter Impacted by Cyclical Nature of the Business
- Oct 07, 2024: Navamedic Wins Joint Nordic Antibiotics Tender
- May 16, 2024: Navamedic : Renewed Contract for Delivering Antibiotics to Norwegian Hospitals
- Apr 30, 2024: Navamedic Q1 2024: Successful product launch and steady operational progress
- Apr 23, 2024: Navamedic Announce Invitation for First Quarter 2024
- Feb 15, 2024: Navamedic Announces Q4 and Full Year 2023
- Feb 15, 2024: Navamedic Q4 and Full Year 2023: A Year Marked by New Records and Transformative Growth Initiatives
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Navamedic ASA, Key Facts
- Navamedic ASA, Key Employees
- Navamedic ASA, Key Employee Biographies
- Navamedic ASA, Major Products and Services
- Navamedic ASA, History
- Navamedic ASA, Other Locations
- Navamedic ASA, Subsidiaries
- Navamedic ASA, Key Competitors
- Navamedic ASA, Ratios based on current share price
- Navamedic ASA, Annual Ratios
- Navamedic ASA, Annual Ratios (Cont...1)
- Navamedic ASA, Annual Ratios (Cont...2)
- Navamedic ASA, Interim Ratios
- Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Navamedic ASA, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Navamedic ASA, Performance Chart (2020 - 2024)
- Navamedic ASA, Ratio Charts
- Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.